Stockholders’ Equity (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Stockholders’ Equity [Abstract] |
|
| Schedule of Restricted Stock Activity |
A summary of restricted stock activity
during the period January 1, 2025 to March 31, 2026 is as follows:
| | |
Total restricted shares | | |
Weighted average fair market value per share | | |
Total unvested restricted shares | |
Weighted average fair market value per share | | |
Total vested restricted shares | | |
Weighted average fair market value per share | |
| Outstanding January 1, 2025 | |
| 783,167 | | |
$ | 1.5000 | | |
| - | |
|
$ | - | | |
| 783,167 | | |
$ | 1.50 | |
| Granted and issued | |
| 67,500,000 | | |
| 0.0037 | | |
| - | |
|
| - | | |
| 67,500,000 | | |
| 0.0037 | |
| Forfeited/Cancelled | |
| - | | |
| - | | |
| - | |
|
| - | | |
| - | | |
| - | |
| Vested | |
| - | | |
| - | | |
| - | |
|
| - | | |
| - | | |
| - | |
| Outstanding December 31, 2025 | |
| 68,283,167 | | |
$ | 0.0207 | | |
| - | |
|
$ | - | | |
| 68,283,167 | | |
$ | 0.0207 | |
| Granted and issued | |
| 50,000,000 | | |
| 0.0126 | | |
| - | |
|
| - | | |
| 50,000,000 | | |
| 0.0126 | |
| Forfeited/Cancelled | |
| - | | |
| - | | |
| - | |
|
| - | | |
| - | | |
| - | |
| Vested | |
| - | | |
| - | | |
| - | |
|
| - | | |
| - | | |
| - | |
| Outstanding March 31, 2026 | |
| 118,283,167 | | |
$ | 0.0173 | | |
| - | |
|
$ | - | | |
| 118,283,167 | | |
$ | 0.0173 | |
|
| Schedule of Expense and Settled Outstanding Liabilities |
The restricted stock granted, issued
and exercisable at March 31, 2026 is as follows:
| | | |
Restricted Stock Granted and Vested | |
| Grant date Price | | |
Number Granted | | |
Weighted Average Fair Value per Share | |
| $ | 0.0037 | | |
| 67,500,000 | | |
| 0.0037 | |
| $ | 0.0126 | | |
| 50,000,000 | | |
| 0.0126 | |
| $ | 1.4700 | | |
| 683,167 | | |
$ | 1.4700 | |
| $ | 1.5000 | | |
| 33,333 | | |
| 1.5000 | |
| $ | 1.6500 | | |
| 66,667 | | |
| 1.6500 | |
| | | | |
| 118,283,167 | | |
$ | 0.0173 | |
|
| Schedule of Expense and Settled Outstanding Liabilities |
The Company has recorded an expense
and settled outstanding liabilities as follows:
| Grant date | | Number
of
shares
granted | | | Vesting
terms | | | Grant
date
fair value | | | Expensed
during
the
period | | | Liability
settled | | | | | | | | | | | | | | | | | | | | February 3, 2026 | | | 50,000,000 | | | | Immediate | | | $ | 630,000 | | | $ | 553,000 | | | $ | 77,000 | |
|
| Schedule of Fair Value of the Warrants Granted and Issued |
The
fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the
following assumptions:
| | |
Three months
ended March 31, 2026 | | |
Year ended December 31, 2025 | |
| | |
| | |
| |
| Exercise price | |
$ | 0.01 to 0.02 | | |
$ | 0.0005 to 0.084 | |
| Risk free interest rate | |
| 3.79 to 3.80 | % | |
| 3.77 to 4.46 | % |
| Expected life of derivative liability | |
| 3 to 5 years | | |
| 1 to 5 years | |
| Expected volatility of underlying stock | |
| 197.25 to 211.22 | % | |
| 183.1 to 352.45 | % |
| Expected dividend rate | |
| 0 | % | |
| 0 | % |
|
| Schedule of Warrant Activity |
A
summary of warrant activity during the period January 1, 2025 to March 31, 2026 is as follows:
| | |
Shares Underlying Warrants | | |
Exercise price per share | | |
Weighted
average exercise price | |
| Outstanding January 1, 2025 | |
| 22,011,614 | | |
$ | 0.084 – 5.625 | | |
$ | 0.319900 | |
| Granted | |
| 55,204,761 | | |
| 0.005 to 0.084 | | |
| 0.00474 | |
| Increase in warrants issued due to anti-dilution price protection | |
| 2,157,367,790 | | |
| 0.0005 | | |
| 0.00050 | |
| Forfeited | |
| (1,853,425,066 | ) | |
| 0.0005 to $4.50 | | |
| 0.00149 | |
| Exercised | |
| (531,165 | ) | |
| 0.0005 to 1.035 | | |
| 0.97430 | |
| Outstanding December 31, 2025 | |
| 380,627,934 | | |
$ | 0.0005 – 5.625 | | |
$ | 0.01052 | |
| Granted | |
| 17,250,000 | | |
| 0.01 to 0.02 | | |
| 0.01072 | |
| Forfeited | |
| (552,438 | ) | |
| 0.0005 to 5.625 | | |
| 2.22652 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Outstanding March 31, 2026 | |
| 397,325,496 | | |
$ | 0.0005 – 1.5000 | | |
$ | 0.00745 | |
|
| Schedule of Warrants Outstanding and Exercisable |
The warrants outstanding and exercisable
at March 31, 2026 are as follows:
| | | | Warrants Outstanding | | | Warrants Exercisable | | | Exercise Price* | | | Number Outstanding | | | Weighted Average Remaining Contractual life in years | | | Weighted Average Exercise Price | | | Number Exercisable | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual life in years | | | $ | 0.000500 | | | | 370,285,776 | | | | 3.01 | | | | | | | | 370,285,776 | | | | | | | | 3.01 | | | $ | 0.010000 | | | | 18,550,000 | | | | 4.90 | | | | | | | | 18,550,000 | | | | | | | | 4.90 | | | $ | 0.020000 | | | | 1,250,000 | | | | 2.97 | | | | | | | | 1,250,000 | | | | | | | | 2.97 | | | $ | 0.345000 | | | | 6,939,718 | | | | 2.45 | | | | | | | | 6,939,718 | | | | | | | | 2.45 | | | $ | 0.450000 | | | | 266,668 | | | | 2.23 | | | | | | | | 266,668 | | | | | | | | 2.23 | | | $ | 1.500000 | | | | 33,334 | | | | 2.37 | | | | | | | | 33,334 | | | | | | | | 2.37 | | | | | | | | 397,325,496 | | | | 3.08 | | | $ | 0.00745 | | | | 397,325,496 | | | $ | 0.00745 | | | | 3.08 | |
|
| Schedule of Option Activity |
A summary of option activity during
the period January 1, 2025 to March 31, 2026 is as follows:
| | |
Shares Underlying options | | |
Exercise price per share | | |
Weighted average exercise price | |
| Outstanding January 1, 2025 | |
| 1,513,335 | | |
$ | 1.20 to 12.00 | | |
$ | 4.47 | |
| Granted | |
| 600,000 | | |
| 0.09 | | |
| 0.09 | |
| Forfeited/Cancelled | |
| (333,334 | ) | |
| 4.50 | | |
| 4.50 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Outstanding December 31, 2025 | |
| 1,780,001 | | |
$ | 0.09 to 12.00 | | |
$ | 2.989 | |
| Granted | |
| - | | |
| - | | |
| - | |
| Forfeited/Cancelled | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Outstanding March 31, 2026 | |
| 1,780,001 | | |
$ | 0.09 to 12.00 | | |
$ | 2.989 | |
|
| Schedule of Options Outstanding and Exercisable |
The options outstanding and exercisable
at March 31, 2026 are as follows:
| | | | Options Outstanding | | | Options Exercisable | | | Exercise Price* | | | Number Outstanding | | | Weighted Average Remaining Contractual life in years | | | Weighted Average Exercise Price | | | Number Exercisable | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual life in years | | | $ | 0.09 | | | | 600,000 | | | | 8.78 | | | | | | | | 425,000 | | | | | | | | 8.78 | | | $ | 1.20 | | | | 13,334 | | | | 6.46 | | | | | | | | 13,334 | | | | | | | | 6.46 | | | $ | 4.50 | | | | 1,166,667 | | | | 5.77 | | | | | | | | 1,166,667 | | | | | | | | 5.77 | | | | | | | | 1,780,001 | | | | 6.79 | | | $ | 2.989 | | | | 1,605,001 | | | $ | 3.305 | | | | 6.79 | |
|